GRCh37/hg19 17p13.1(chr17:6934163-8217978)x1 AND Poly (ADP-Ribose) polymerase inhibitor response
- Germline classification:
- drug response (1 submission)
- Last evaluated:
- Nov 27, 2017
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000626431.1
Allele description [Variation Report for GRCh37/hg19 17p13.1(chr17:6934163-8217978)x1]
GRCh37/hg19 17p13.1(chr17:6934163-8217978)x1
Condition(s)
- Name:
- Poly (ADP-Ribose) polymerase inhibitor response
- Synonyms:
- PARP Inhibitor response
- Identifiers:
- MedGen: CN322715
Assertion and evidence details
Last Updated: Mar 26, 2023